ManaT Bio

Clasp Therapeutics specializes in transforming immuno-oncology through the development of precision immunotherapies, specifically next-generation T cell engagers that target cancer with high specificity. The company aims to address the needs of patients with hard-to-treat tumors by leveraging cancer-specific markers and engineered pHLAre molecules... for tailored treatment across various tumor types. Their innovative approach allows for effective targeting of oncogenic drivers within cancer cells, providing hope for those whose cancers do not respond to existing therapies. Clasp Therapeutics is dedicated to expanding the potential of immuno-oncology to enhance the lives of patients globally.Read More